Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) in mCRC Patients Treated With First-line Bevacizumab
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 15 Dec 2016 Planned End Date changed from 1 Jul 2019 to 1 Apr 2017.
- 15 Dec 2016 Status changed from active, no longer recruiting to discontinued.
- 25 Nov 2016 Status changed from recruiting to active, no longer recruiting.